Differentiation Therapy in Acute Myelogenous Leukemia (Non-Apl)

Leukemia - United Kingdom
doi 10.1038/sj.leu.2401714
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Therapy-Related Myelodysplastic Syndrome-Acute Myelogenous Leukemia in Patients Treated for Acute Promyelocytic Leukemia: An Emerging Problem

Blood
BiochemistryImmunologyCell BiologyHematology
2002English

New Agents for Acute Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Clinical Challenges and Consequences of Measurable Residual Disease in Non-Apl Acute Myeloid Leukemia

Cancers
Cancer ResearchOncology
2019English

P53 in Chronic Myelogenous Leukemia in Acute Phase.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Treatment of Acute Myelogenous Leukemia in Older Adults

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Acute Myelogenous Leukemia With Leptotrichia Trevisanii Bacteremia

Internal Medicine
Internal MedicineMedicine
2013English

Mouse Model for Early Acute Promyelocytic Leukemia (APL)

Science-Business eXchange
2011English

DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2015English

Molecular Pathways: Targeting NRAS in Melanoma and Acute Myelogenous Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy